Literature DB >> 7067167

Platelet function in patients on maintenance hemodialysis: depressed or enhanced?

G Remuzzi, A Benigni, P Dodesini, A Schieppati, E Gotti, M Livio, G Mecca, B Donati, G de Gaetano.   

Abstract

Uremic patients on long-term hemodialysis show a paradoxical association of hemorrhages on the one hand and thrombotic complications or atherosclerosis on the other. Platelet function has been found to be depressed in some cases but enhanced in others. In 19 patients, both platelet aggregation and prostaglandin formation appeared to be significantly enhanced in response to low concentrations of arachidonic acid but significantly reduced with high concentrations. It is suggested that this double functional abnormality of uremic platelets may contribute to the complex vascular disturbances of hemodialyzed patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7067167

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

1.  Clinical outcome following coronary angioplasty in dialysis patients: a case-control study in the era of coronary stenting.

Authors:  C Le Feuvre; G Dambrin; G Helft; F Beygui; M Touam; J P Grünfeld; A Vacheron; J P Metzger
Journal:  Heart       Date:  2001-05       Impact factor: 5.994

2.  Characteristics of nonvariceal upper gastrointestinal hemorrhage in patients with chronic kidney disease.

Authors:  Chang Seok Bang; Yong Seop Lee; Yun Hyeong Lee; Hotaik Sung; Hong Jun Park; Hyun Soo Kim; Jin Bong Kim; Gwang Ho Baik; Yeon Soo Kim; Jai Hoon Yoon; Dong Joon Kim; Ki Tae Suk
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

3.  Coagulation factors as biological risk markers of endothelial dysfunction. Association with the thrombotic episodes of chronic hemodialysis patients.

Authors:  A Sioulis; P Malindretos; A Makedou; P Makris; D Grekas
Journal:  Hippokratia       Date:  2009-10       Impact factor: 0.471

4.  Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.

Authors:  G Remuzzi; A Benigni; P Dodesini; A Schieppati; M Livio; G De Gaetano; S S Day; W L Smith; E Pinca; P Patrignani; C Patrono
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

5.  [Use of low molecular-weight heparin in hemodialysis patients].

Authors:  J Schrader; J Rieger; H Müschen; W Stibbe; H Köstering; P Kramer; F Scheler
Journal:  Klin Wochenschr       Date:  1985-01-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.